Skip to content
zameds

Enoxaparin

Sold as Clexane, Clexiwin, Noxfibra, Crusia, Ivenoxin

S4Read from the PI-PIL document and verified

No structure available

This product's active ingredient could not be matched to a single known compound.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
4
Registrations
25
Schedule source
SAHPRA documentation

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Sanofi-aventis South Africa (Pty) LtdCertificate held by Sanofi-aventis5 of 11 cancelledClexane, Clexiwin20, 40, 60, 80, 100, 300310480, 310481, 310482, 320122, 420193, 420194, 420195, 420196, 420198, A390079, X0042S4PIPIL
Sandoz South Africa (Pty) LtdNoxfibra20, 40, 60, 80, 100520495, 520496, 520497, 520498, 520499S4None
Adcock Ingram Critical Care (Pty) LtdCertificate held by Adcock ingram limitedCrusia20, 40, 60, 80, 100550009, 550010, 550011, 550012, 550013S4PIPIL
Kahma Biotech (Pty) LtdIvenoxin20, 40, 80, 100560815, 560816, 560818, 560819S4None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Clexane 60

EACH 0,6 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 60,0 mg

60Solution for injection31048031/8.2/0480Approved 13 October 2023RegisteredS4PIPIL
Clexane 80

EACH 0,8 ml SOLUTION CONTAINS:ENOXAPARIN SODIUM 80,0 mg

80Solution for injection31048131/8.2/0481Approved 13 October 2023RegisteredS4PIPIL
Clexane 100

EACH 1,0 ml SOLUTION CONTAINS:ENOXAPARIN SODIUM 100,0 mg

100Solution for injection31048231/8.2/0482Approved 13 October 2023RegisteredS4PIPIL
Clexane 300

EACH 3,0 ml SOLUTION CONTAINS:ENOXAPARIN SODIUM 300,0 mg

300Solution for injection32012232/8.2/0122Approved 13 October 2023RegisteredS4PIPIL
Clexiwin 20

EACH 0,2 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 20,0 mg

2042019342/8.2/0193CancelledS4None
Clexiwin 40

EACH 0,4 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 40,0 mg

4042019442/8.2/0194CancelledS4None
Clexiwin 60

EACH 0,6 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 60,0 mg

6042019542/8.2/0195CancelledS4None
Clexiwin 80

EACH 0,6 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 80,0 mg

8042019642/8.2/0196CancelledS4None
Clexiwin 300

EACH 3,0 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 300,0 mg

30042019842/8.2/0198CancelledS4None
Noxfibra 20

EACH 0,2 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 20,0 mg

2052049552/8.2/0495RegisteredS4None
Noxfibra 40

EACH 0,4 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 20,0 mg

4052049652/8.2/0496RegisteredS4None
Noxfibra 60

EACH 0,6 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 60,0 mg

6052049752/8.2/0497RegisteredS4None
Noxfibra 80

EACH 0,8 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 80,0 mg

8052049852/8.2/0498RegisteredS4None
Noxfibra 100

EACH 1,0 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 100,0 mg

10052049952/8.2/0499RegisteredS4None
Crusia 20

Each 0,2 ml Solution contains: Enoxaparin Sodium 20,0 mg

20Solution for injection55000955/8.2/0009Approved 19 April 2022RegisteredS4PIPIL
Crusia 40

Each 0,4 ml Solution contains: Enoxaparin Sodium 40,0 mg

40Solution for injection55001055/8.2/0010Approved 19 April 2022RegisteredS4PIPIL
Crusia 60

Each 0,6 ml Solution contains: Enoxaparin Sodium 60,0 mg

60Solution for injection55001155/8.2/0011Approved 19 April 2022RegisteredS4PIPIL
Crusia 80

Each 0,8 ml Solution contains: Enoxaparin Sodium 80,0 mg

80Solution for injection55001255/8.2/0012Approved 19 April 2022RegisteredS4PIPIL
Crusia 100

Each 0,1 ml Solution contains: Enoxaparin Sodium 100,0 mg

100Solution for injection55001355/8.2/0013Approved 19 April 2022RegisteredS4PIPIL
Ivenoxin 20

EACH 0,2 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 20,0 mg

2056081556/8.2/0815RegisteredS4None
Ivenoxin 40

EACH 0,4 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 40,0 mg

4056081656/8.2/0816RegisteredS4None
Ivenoxin 80

EACH 0,8 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 80,0 mg

8056081856/8.2/0818RegisteredS4None
Ivenoxin 100

EACH 10,0 ml SOLUTION CONTAINS ENOXAPARIN SODIUM 100,0 mg

10056081956/8.2/0819RegisteredS4None
Clexane 20

EACH 0,2 ml SOLUTION CONTAINS: ENOXAPARIN SODIUM 20,0 mg

20Solution for injectionA390079A39/8.2/0079Approved 13 October 2023RegisteredS4PIPIL
Clexane 40

EACH 0,4 ml SOLUTION CONTAINS ENOXAPARIN 40 mg

40Solution for injectionX0042X/8.2/42Approved 13 October 2023RegisteredS4PIPIL

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Enoxaparin sodium

  • S4: Enoxaparin

    Consolidated Schedules 06 July 2026, line 6186

Pharmacological class: Anticoagulants. (class 8.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Clexane 60, Sanofi-aventis South Africa (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsClexane 60, Sanofi-aventis South Africa (Pty) LtdPatient information leaflet (PIL)For patients and carersClexane 60, Sanofi-aventis South Africa (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles